VIDAS® LH

GUDID 03573026156930

VIDAS® LH (LH) assay is a quantitative immunoassay intended for use on VIDAS family instrument in the detection of LH concentration in human serum or plasma .

BIOMERIEUX SA

Luteinizing hormone (LH) IVD, kit, enzyme immunoassay (EIA)

• Primary Device ID: 03573026156930
• NIH Device Record Key: 25386b28-baff-40b9-a68a-7f0458777ef4
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: VIDAS® LH
• Version Model Number: 30406-01
• Company DUNS: 276816717
• Company Name: BIOMERIEUX SA
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: true
• Device Combination Product: false
• Single Use: false
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Operating and Storage Conditions

• Storage Environment Temperature: Between 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	03573026156930 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Notification: K921176

FDA Product Code

• CEP: RADIOIMMUNOASSAY, LUTEINIZING HORMONE

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: New
• Device Record Status: Published
• Public Version Number: 1
• Public Version Date: 2019-11-13
• Device Publish Date: 2019-11-05

Devices Manufactured by BIOMERIEUX SA

• 03573026256685 - ETEST® Gentamicin (GM): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026376604 - ETEST® Amoxicillin (AC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026377731 - ETEST® Flucytosine (FC): 2024-04-15 Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions
• 03573026560690 - ETEST® Meropenem/Vaborbactam (MEV): 2024-04-15 ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative an
• 03573026475352 - ETEST® Telavancin (TLA): 2024-04-12 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026252526 - ETEST® Cefepime (PM): 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026253219 - Etest® TIC/CLAV-CON2: 2024-04-08 Etest is a quantitative technique for determining susceptibility of clinically significant bacteria. It provides a gradient of 1
• 03573026617851 - VITEK®MS: 2024-03-18 VITEK MS ready to use reagent for calibration and fine tuning of the VITEK MS instrument